Related Experiment Video
Updated: Aug 9, 2026

In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells
Published on: October 23, 2018
Desflurane reduces the febrile response to administration of interleukin-2
C Negishi1, R Lenhardt, D I Sessler
1Department of Anesthesia and Perioperative Care, University of California, San Francisco, 94143-0648, USA.
Background:
Intraoperative fever is relatively rare considering how often pyrogenic causes are likely to be present and how common fever is postoperatively. This low incidence suggests that general anesthesia per se inhibits the normal response to pyrogenic stimulation. The authors therefore tested the hypothesis that desflurane-induced anesthesia produces a dose-dependent inhibition of the febrile response.
Methods:
Eight volunteers were studied, each on 3 study days. Each was given an intravenous injection of 50,000 IU/ kg of interleukin-2 (elapsed time, 0 h), followed 2 h later by 100,000 IU/kg. One hour after the second dose, the volunteers were assigned randomly to three doses of desflurane to induce anesthesia: (1) 0.0 minimum alveolar concentration (MAC; control), (2) 0.6 MAC, and (3) 1.0 MAC. Anesthesia continued for 5 h. Core temperatures were recorded from the tympanic membrane. Thermoregulatory vasoconstriction was evaluated using forearm-minus-fingertip skin temperature gradients; shivering was evaluated with electromyography. Integrated and peak temperatures during anesthesia were compared with repeated-measures analysis of variance and Scheffé's F tests.
Results:
Values are presented as mean +/- SD. Desflurane reduced the integrated (area under the curve) febrile response to pyrogen, from 7.7 +/- 2.0 degrees C x h on the control day to 2.1 +/- 2.3 degrees C x h during 0.6 MAC and to -1.4 +/- 3.1 degrees C x h during 1.0 MAC desflurane-induced anesthesia. Peak core temperature (elapsed time, 5-8 h) decreased in a dose-dependent fashion: 38.6 +/- 0.5 degrees C on the control day, 37.7 +/- 0.7 degrees C during 0.6 MAC and 37.2 +/- 1.0 degrees C during 1.0 MAC desflurane anesthesia. Rising core temperature was always associated with fingertip vasoconstriction and often with shivering.
Conclusions:
Desflurane-induced anesthesia produced a dose-dependent decrease in integrated and peak core temperatures after administration of pyrogen, with 1.0 MAC essentially obliterating fever. Anesthetic-induced inhibition of the pyrogenic response is therefore one reason that fever is an inconsistent clinical response to inflammation during surgery.
Insights
General anesthesia with desflurane inhibits the body's fever response in a dose-dependent manner. Higher doses of desflurane significantly reduced or even abolished fever caused by pyrogens.
Area of Science:
- Anesthesiology
- Physiology
- Immunology
Background:
- Intraoperative fever is uncommon despite potential pyrogenic stimuli.
- General anesthesia may inhibit the febrile response to pyrogens.
- This study investigated desflurane's effect on fever.
Purpose of the Study:
- To test if desflurane anesthesia inhibits the febrile response in a dose-dependent manner.
- To quantify the effect of different desflurane concentrations on pyrogen-induced fever.
Main Methods:
- Eight volunteers received interleukin-2 to induce fever.
- Volunteers were anesthetized with desflurane at 0.0, 0.6, or 1.0 minimum alveolar concentration (MAC).
- Core temperature, vasoconstriction, and shivering were monitored.
Main Results:
- Desflurane reduced the integrated febrile response in a dose-dependent manner.
- Peak core temperature decreased with increasing desflurane concentration.
- 1.0 MAC desflurane anesthesia nearly abolished the fever response.
Conclusions:
- Desflurane anesthesia inhibits pyrogen-induced fever in a dose-dependent way.
- Anesthetic-induced suppression of the pyrogenic response explains inconsistent fever during surgery.
- Desflurane is a potent inhibitor of fever.
More Related Videos
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
03:02Application of Dixon's Up-and-Down Design to Estimate the Minimum Alveolar Concentration of Sevoflurane in Rats with Refined Movement Classification
Published on: July 25, 2025
Related Concept Videos
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Depolarizing Blockers: Pharmocokinetics
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Skeletal Muscle Relaxants: Therapeutic Uses
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview